KR20170035345A - High SPF W/O type cosmetic composition having no stickiness - Google Patents
High SPF W/O type cosmetic composition having no stickiness Download PDFInfo
- Publication number
- KR20170035345A KR20170035345A KR1020160121719A KR20160121719A KR20170035345A KR 20170035345 A KR20170035345 A KR 20170035345A KR 1020160121719 A KR1020160121719 A KR 1020160121719A KR 20160121719 A KR20160121719 A KR 20160121719A KR 20170035345 A KR20170035345 A KR 20170035345A
- Authority
- KR
- South Korea
- Prior art keywords
- oil
- ultraviolet
- water
- composition
- blocking
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 73
- 239000002537 cosmetic Substances 0.000 title abstract description 9
- 230000000903 blocking effect Effects 0.000 claims abstract description 14
- 239000000516 sunscreening agent Substances 0.000 claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 239000003921 oil Substances 0.000 claims description 69
- 238000012216 screening Methods 0.000 claims description 52
- 239000003795 chemical substances by application Substances 0.000 claims description 31
- 239000000843 powder Substances 0.000 claims description 24
- 239000000341 volatile oil Substances 0.000 claims description 23
- 239000012071 phase Substances 0.000 claims description 16
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000008346 aqueous phase Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- RGMZNZABJYWAEC-UHFFFAOYSA-N Methyltris(trimethylsiloxy)silane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C RGMZNZABJYWAEC-UHFFFAOYSA-N 0.000 claims description 3
- 239000002981 blocking agent Substances 0.000 claims description 3
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical group N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 claims description 3
- 229940073663 methyl trimethicone Drugs 0.000 claims description 3
- 229960000655 ensulizole Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 16
- 238000009472 formulation Methods 0.000 abstract description 10
- 235000019198 oils Nutrition 0.000 description 46
- 210000003491 skin Anatomy 0.000 description 15
- -1 glyceryl paraben Chemical compound 0.000 description 9
- 206010015150 Erythema Diseases 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 239000004205 dimethyl polysiloxane Substances 0.000 description 8
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 231100000321 erythema Toxicity 0.000 description 8
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 8
- 229920001223 polyethylene glycol Polymers 0.000 description 8
- 239000001993 wax Substances 0.000 description 8
- 239000004166 Lanolin Substances 0.000 description 7
- 229940008099 dimethicone Drugs 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 235000019388 lanolin Nutrition 0.000 description 7
- 229940039717 lanolin Drugs 0.000 description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 230000004888 barrier function Effects 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000003995 emulsifying agent Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 229920002545 silicone oil Polymers 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 229920006328 Styrofoam Polymers 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000008261 styrofoam Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000006750 UV protection Effects 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 229960001679 octinoxate Drugs 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 230000037072 sun protection Effects 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- MRIXVKKOHPQOFK-UHFFFAOYSA-N 4-methoxysalicylic acid Chemical compound COC1=CC=C(C(O)=O)C(O)=C1 MRIXVKKOHPQOFK-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000021357 Behenic acid Nutrition 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 229940116226 behenic acid Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000000346 nonvolatile oil Substances 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 229960001173 oxybenzone Drugs 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 201000000849 skin cancer Diseases 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PYJQLUORHGLSGS-UHFFFAOYSA-N 16-methylheptadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C PYJQLUORHGLSGS-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- RTEZXFBVXJPHKS-UHFFFAOYSA-N 2,2-dimethylpropanoic acid;2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(C)(C)C(O)=O.CC(O)COC(C)COC(C)CO RTEZXFBVXJPHKS-UHFFFAOYSA-N 0.000 description 1
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- KZYKVEGBVFDESS-UHFFFAOYSA-N 2-hexoxy-3-hexylbenzoic acid Chemical compound CCCCCCC1=C(C(=CC=C1)C(=O)O)OCCCCCC KZYKVEGBVFDESS-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- WNKDGVYPOHXOMT-UHFFFAOYSA-N 3-hexoxy-2-methoxyphenol Chemical compound C(CCCCC)OC=1C(=C(C=CC1)O)OC WNKDGVYPOHXOMT-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- YUXBNNVWBUTOQZ-UHFFFAOYSA-N 4-phenyltriazine Chemical compound C1=CC=CC=C1C1=CC=NN=N1 YUXBNNVWBUTOQZ-UHFFFAOYSA-N 0.000 description 1
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methyloxysalicylic acid Natural products COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- ACFGRWJEQJVZTM-LEJBHHMKSA-L Magnesium L-ascorbic acid-2-phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1O ACFGRWJEQJVZTM-LEJBHHMKSA-L 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 101100459248 Mus musculus Mxra8 gene Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 1
- OOHTWBUKWQKKEE-UHFFFAOYSA-N [6-(diethylamino)-6-hydroxy-7-oxo-7-phenylheptyl] benzoate Chemical compound C=1C=CC=CC=1C(=O)C(O)(N(CC)CC)CCCCCOC(=O)C1=CC=CC=C1 OOHTWBUKWQKKEE-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 229940116224 behenate Drugs 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- OSPYXUDVXSLVLJ-UHFFFAOYSA-N calcium cerium(3+) oxygen(2-) Chemical compound [Ca+2].[O-2].[Ce+3] OSPYXUDVXSLVLJ-UHFFFAOYSA-N 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000012185 ceresin wax Substances 0.000 description 1
- 229940061628 chromium hydroxide green Drugs 0.000 description 1
- 229940035427 chromium oxide Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- CYYGBBNBGCVXEL-UHFFFAOYSA-N chromium(3+);oxygen(2-);dihydrate Chemical compound O.O.[O-2].[O-2].[O-2].[Cr+3].[Cr+3] CYYGBBNBGCVXEL-UHFFFAOYSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- GLCJMPWWQKKJQZ-UHFFFAOYSA-L disodium;2-[4-(4,6-disulfonato-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonate;hydron Chemical compound [Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O GLCJMPWWQKKJQZ-UHFFFAOYSA-L 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229960004697 enzacamene Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 229940100242 glycol stearate Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IIGMITQLXAGZTL-UHFFFAOYSA-N octyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC IIGMITQLXAGZTL-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 229940031709 peg-30-dipolyhydroxystearate Drugs 0.000 description 1
- 229940088608 peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- 229920009537 polybutylene succinate adipate Polymers 0.000 description 1
- 229910021420 polycrystalline silicon Inorganic materials 0.000 description 1
- 229920000059 polyethylene glycol stearate Polymers 0.000 description 1
- 229920005591 polysilicon Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000004170 rice bran wax Substances 0.000 description 1
- 235000019384 rice bran wax Nutrition 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000021148 sequestering of metal ion Effects 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 229940057429 sorbitan isostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
- A61K8/0225—Granulated powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0279—Porous; Hollow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 우수한 자외선 차단 기능을 가지면서 끈적임은 줄어들어 사용감이 뛰어난 유중수형(W/O) 자외선 차단 화장료 조성물에 관한 것이다.The present invention relates to a water-in-oil (W / O) ultraviolet light cosmetic composition having an excellent ultraviolet shielding function and a reduced stickiness to provide a feeling of use.
최근 환경오염으로 인해 오존층이 파괴되어 자외선 노출이 심화되고 있으며, 이러한 자외선은 피부에 홍반, 부종, 주근깨, 피부암 등을 일으키는 주요 원인으로 작용한다. 이에 따라 최근 자외선으로부터 피부를 보호하는 제품의 개발이 요구되고 있다. 특히, 삶이 윤택해지면서 생활 자외선으로부터 피부를 보호하고자 하는 욕구뿐만 아니라, 스키, 골프, 해수욕 등의 레저활동 인구가 늘어나면서 자외선으로부터 피부를 보호하는 요구가 늘어가고 있고, 이러한 요구를 만족시키기 위해 수많은 연구가 진행되고 있다.Recently, the ozone layer has been destroyed due to environmental pollution and exposure to ultraviolet rays has been intensified. Such ultraviolet rays are a major cause of causing erythema, edema, freckles, and skin cancer in the skin. Accordingly, there has recently been a demand for development of a product that protects skin from ultraviolet rays. Especially, as the life becomes more and more, not only the desire to protect the skin from living ultraviolet rays but also the demand for protecting the skin from the ultraviolet rays is increasing as the leisure activity population such as skiing, golf, and bathing water is increased. Research is underway.
일반적으로 자외선은 파장에 따라 3개의 영역으로 구분되며, 200-290 nm의 파장은 자외선 C(UVC), 290-320 nm의 파장은 자외선 B(UVB), 및 320-400 nm의 파장은 자외선 A(UVA)로 분류된다. 그 중 UVC는 오존층을 통과하면서 지표면에 도달하지 못하고 소실되며, UVB는 피부의 표피까지 침투되어 홍반, 주근깨, 부종 등을 일으킨다. UVA는 피부의 진피까지 침투하여 피부암, 주름, 및 멜라닌 형성을 촉진하는 등, 피부 노화 및 피부자극을 유발하는 것으로 알려져 있다.In general, ultraviolet rays are divided into three regions according to wavelength, ultraviolet C (UVC) at a wavelength of 200-290 nm, ultraviolet B (UVB) at a wavelength of 290-320 nm, and ultraviolet A (UVA). Among them, UVC passes through the ozone layer and disappears without reaching the surface. UVB penetrates into the epidermis of the skin, causing erythema, freckles and edema. UVA penetrates the skin's dermis and promotes skin cancer, wrinkles, and melanin formation, leading to skin aging and skin irritation.
장파장 자외선(UVA)은 진피층 내 단백질의 변성, 모세혈관 확장, 핵산(DNA)의 파괴 등에 의한 피부노화를 촉진하여 경계의 대상으로 지목되고 있다. 한편, 피부의 표피 부분에서 대부분 흡수되는 중파장 자외선(UV-B)은 표피에 급격히 작용하여 화상을 입히기 때문에 유해 자외선이라 부르기도 한다. 장파장 자외선은 1년 내내 피부에 와 닿고 있지만 자각증상이 없기 때문에 자기 자신도 모르는 사이에 피부는 늙게 된다.The long wavelength ultraviolet (UVA) has been designated as a boundary object by promoting skin aging by protein denaturation in the dermis, capillary expansion, and destruction of DNA (DNA). On the other hand, the medium-wave ultraviolet (UV-B), which is mostly absorbed in the epidermis of the skin, is called harmful ultraviolet rays because it rapidly acts on the epidermis and burns. The long wavelength ultraviolet rays reach the skin all year round, but because they do not have any subjective symptoms, the skin becomes old without knowing oneself.
태양광 노출에 의한 위험이 알려지면서 자외선 차단 제품에 대한 대중들의 관심이 증가하였고, 이에 따라 우수한 자외선차단지수(Sun Protection Factor, SPF) 및 자외선A차단등급(Protection grade of UVA, PA)을 가지는 제품이 출시되고 있다.As the risk of exposure to sunlight became known, the public's interest in UV protection products increased, and accordingly, products with superior Sun Protection Factor (SPF) and UV Protection Class (UVA, PA) Is being released.
자외선 차단 제품은 최근 계절과 상관없이 사용하는 제품으로 인식되어 오고 있으나, 특히 하절기에 많이 사용하고, 따라서 피지 분비로 인한 심한 오일감과 화장막 붕괴로 인한 문제점이 지속적으로 제기되어 왔다. Ultraviolet shielding products have been recognized as products to be used irrespective of season, but they have been used frequently in the summer season, and therefore, problems caused by severe oily feeling due to sebum secretion and collapse of the membrane have been continuously raised.
또한, 통상적으로, 자외선 차단 제품은 땀이나 물에 대한 내수성을 향상시키기 위해 유상을 외상으로 하는 유중수형(W/O) 제형으로 제조된다. 수중유형(O/W) 타입의 자외선 차단 제품은 산뜻한 사용감을 제공한다는 장점은 있으나, 땀이나 물에 쉽게 씻겨 나가 지속성이 현저히 떨어진다는 단점이 있기 때문이다. 그러나 지속성이 우수한 유중수형 타입의 자외선 차단 제품은 무거운 사용감과 함께 끈적이거나 유분감이 있다는 단점이 있으며, 수중유형 타입에 비해 안정성이 떨어지는 것으로 알려져 있고, 장기간 보관시 수상과 외상이 분리되는 것으로 알려져 있다. 특히, 휘발성 오일을 다량 함유한 유중수형 타입은 유화 안정성이 불안하여 유상과 수상이 분리되기 쉬워 흔들어 사용하는 쉐이킹 제형에 국한되어 제형화되나, 이러한 제형 또한 여러 문제점을 내포하고 있다.Further, usually, the ultraviolet screening product is manufactured into a water-in-oil type (W / O) formulation in which the oil phase is traumatized to improve water resistance to sweat and water. UV protection products of the underwater type (O / W) type have a merit of providing refreshing feeling, but they are easily washed out with sweat and water, and there is a disadvantage that the persistence is remarkably deteriorated. However, it has been known that the ultraviolet screening product having excellent durability has a disadvantage that it is sticky or oily with heavy use feeling, and is less stable than the underwater type type, and it is known that the water and the trauma are separated during long-term storage. Particularly, a water-in-oil type containing a large amount of volatile oil is limited to shaking formulations which are easily disturbed from oil and water due to unstable emulsification stability, but these formulations also have various problems.
따라서 본 발명이 해결하고자 하는 과제는 끈적임이 줄어들어 사용감이 뛰어나면서 제형 안정성이 개선된 우수한 자외선 차단 효과를 갖는 유중수형 타입의 자외선 차단 화장료 조성물 및 이의 제조방법을 제공하는 것이다. Accordingly, it is an object of the present invention to provide a water-in-oil type ultraviolet ray blocking cosmetic composition having excellent ultraviolet ray shielding effect with improved stability in formulation, which is excellent in use feeling due to reduced stickiness, and a method for producing the same.
상술한 과제를 해결하기 위하여, 본 발명은 끈적임이 줄어들어 사용감이 뛰어나면서 제형 안정성이 개선된 우수한 자외선 차단 효과를 갖는 유중수형 타입의 자외선 차단 화장료 조성물 및 이의 제조방법을 제공한다. Disclosure of the Invention In order to solve the above-described problems, the present invention provides a UV-blocking cosmetic composition of the water-in-oil type having excellent ultraviolet shielding effect with improved stability in formulation and reduced feeling of tackiness.
보다 구체적으로, 유중수형의 자외선 차단용 조성물로서, More specifically, as a water-in-oil type UV blocking composition,
ⅰ. 유기 자외선 차단제를 포함하되, 상기 유기 자외선 차단제로 수용성 유기 자외선 차단제가 선택되며, I. A water-soluble organic ultraviolet screening agent is selected as the organic ultraviolet screening agent,
ⅱ. 유상 성분의 총 중량 대비 80 중량% 이상이 휘발성 오일인 것을 특징으로 하는, 자외선 차단용 조성물을 제공한다. Ii. Wherein at least 80% by weight based on the total weight of the oil phase component is a volatile oil.
본 발명자들은 유기 자외선 차단제를 포함하되, 유용성 유기 자외선 차단제를 배제하고 수용성 자외선 차단 성분만을 사용하여, 우수한 자외선 차단 효과를 부여 할 수 있음을 확인하였다. 동시에, 유중수형 타입의 단점인 끈적임과 유분감을 해결하기 위해 다양한 노력을 기울인 결과, 유상 성분으로 휘발성이 있는 성분들을 사용하면 유중수형 타입의 단점을 해소할 수 있음을 발견하고, 본 발명을 완성하였다. 추가로, 흡유성 분체나 폴리머(다공성, 중공성)를 사용하면 유화 안정성을 향상시키고 피지흡착에 의해 지속성까지 향상시킬 수 있음을 확인하고, 본 발명에 이르게 되었다. The present inventors have confirmed that an organic UV-screening agent is included, but an oil-soluble ultraviolet screening agent is excluded and only a water-soluble ultraviolet-shielding component is used, thereby providing an excellent ultraviolet screening effect. At the same time, various efforts have been made to solve the stickiness and oiliness which are disadvantages of the water-in-oil type, and as a result, it has been found that the disadvantages of the water-in-oil type can be solved by using volatile components as the oil component, . Further, it has been confirmed that the use of an oil absorbing powder or polymer (porous, hollow) improves emulsion stability and sustainability can be improved by sebum adsorption, leading to the present invention.
이하, 본 발명에 따른 자외선 차단용 조성물 및 이이 제조방법에 대해 구체적으로 설명한다. BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the ultraviolet screening composition and the method for producing the same according to the present invention will be described in detail.
본 발명에 따른 명세서에 있어서, 용어 “자외선 차단제”에는 자외선을 산란, 반사 또는 흡수하는 등의 기전으로 피부에 도달한 자외선을 차단할 수 있는 성분이라면 모두 포함될 수 있으며, 자외선 차단제는 무기 자외선 차단제 및 유기 자외선 차단제로 구분될 수 있다. In the specification of the present invention, the term " ultraviolet screening agent " may include any ingredient capable of blocking ultraviolet rays reaching the skin through a mechanism such as scattering, reflecting or absorbing ultraviolet rays. And sunscreen agents.
본 발명에 따른 자외선 차단용 조성물은 유기 자외선 차단제를 포함한다. The ultraviolet screening composition according to the present invention includes an organic ultraviolet screening agent.
상기 유기 자외선 차단제는 자외선 흡수 효과가 있고 백탁 현상이 없다는 장점이 있으며, 유용성 (유기) 자외선 차단제와 수용성 (유기) 자외선 차단제로 구분될 수 있다. 예컨대, 유용성 자외선 차단제로는 4-메칠벤질리덴캠퍼, 디소듐페닐디벤즈아미다졸테트라설포네이트, 디에칠헥실부타미도프리아존, 메칠렌비스-벤조트리아졸릴테트라메칠부틸페놀, 에칠헥실디메칠파바, 테레프탈릴리덴디캠퍼설포닉애씨드 및 그 염류, 글리세릴파바, 드로메트리졸, 드로메트리졸트리실록산, 디갈로일트리올레이트, 3-(4-메칠벤질리덴)-캄파, 메틸안트라닐레이트, 비스-에칠헥실옥시페놀메톡시페닐트리아진, 디에칠아미노하이드록시 벤조일헥실벤조에이트, 벤조페논-3, 벤조페논-4, 벤조페논-8, 부틸메톡시디벤조일메탄, 시녹세이트, 에칠헥실트리아존, 옥틸메톡시신나메이트, 옥토크릴렌, 옥틸디메칠파바, 옥틸살리실레이트, 옥시벤존, 시녹세이트, 옥틸트리아존, 에칠헥실메톡시신나메이트, 에칠헥실살리실레이트, 파라아미노안식향산, 호모살레이트, 이소아밀-p-메톡시신신나메이트, 비스에칠헥실옥시페놀메톡시페닐트리아진, 및 폴리실리콘-15 등이 포함되나 이에 제한되지 않는다. 또한, 예컨대, 수용성 자외선 차단제로는 2-페닐벤즈이미다졸-5-설폰산, 테레프탈릴리덴디캠퍼설포닉애씨드 및 그 염류 등이 포함될 수 있으나, 이에 제한되지 않는다. The organic ultraviolet screening agent has an ultraviolet absorbing effect and has no whitening phenomenon. The organic ultraviolet screening agent can be classified into an oil-soluble (organic) ultraviolet screening agent and a water-soluble (organic) ultraviolet screening agent. Examples of usable ultraviolet light blocking agents include 4-methylbenzylidene camphor, disodium phenyldibenzimidazole tetrasulfonate, diethylhexylbutamidopriazone, methylenebis-benzotriazolyltetramethylbutylphenol, , Terephthalylidene dicam persulfonic acid and its salts, glyceryl paraben, drometrizol, drometrizol trisiloxane, dipaloyyl trioleate, 3- (4-methylbenzylidene) -campa, methyl anthranilate, Bis-ethylhexyloxyphenol methoxyphenyltriazine, diethylaminohydroxybenzoylhexylbenzoate, benzophenone-3, benzophenone-4, benzophenone-8, butylmethoxydibenzoylmethane, cyoxsite, ethylhexyltriazone , Octyl methoxycinnamate, octocrylene, octyldimethylpivalate, octyl salicylate, oxybenzone, cyoxylate, octyltriazone, ethylhexylmethoxycinnamate, hexylhexylsalicylate, Acid, homo-year-old rate, isoamyl -p- body methoxy cinnamate, fill to bis hexyloxy-methoxy phenol, but include phenyl triazine, and the polysilicon -15 is not limited thereto. Further, for example, the water-soluble ultraviolet screening agent may include, but is not limited to, 2-phenylbenzimidazole-5-sulfonic acid, terephthalylidene dicampersulfic acid and salts thereof.
본 발명에 따른 자외선 차단용 조성물은 유기 자외선 차단제를 포함하되, 상기 유기 자외선 차단제로 수용성 유기 자외선 차단제가 선택된다. 즉, 유용성 유기 자외선 차단제는 실질적으로 포함하지 않는다. The ultraviolet screening composition according to the present invention includes an organic ultraviolet screening agent, and the water-soluble organic ultraviolet screening agent is selected as the organic ultraviolet screening agent. That is, it does not substantially contain an oil-soluble organic sunscreen agent.
본 발명에 따른 명세서에 있어서, 용어 "실질적으로 포함하지 않는다(않거나)"는 자외선 차단용 조성물의 총 중량 대비 5 중량% 미만, 4 중량% 미만, 3 중량% 미만, 2 중량% 미만, 1 중량% 미만, 0.5 중량% 미만, 0.05 중량% 미만, 0.0005 중량% 미만, 또는 바람직하게 0.00001 중량% 미만, 가장 바람직하게 0 중량%인 것을 의미한다. The term "substantially free (or not)" in the context of the present invention is meant to include less than 5 wt%, less than 4 wt%, less than 3 wt%, less than 2 wt% %, Less than 0.5%, less than 0.05%, less than 0.0005%, or preferably less than 0.00001% by weight, most preferably 0% by weight.
본 발명에 따른 자외선 차단용 조성물의 총 중량 대비 수용성 유기 자외선 차단제는 1 - 10 중량%로 포함되며, 보다 바람직하게 1 - 5 중량%로 포함될 수 있다. The water-soluble organic ultraviolet screening agent may be contained in an amount of 1 to 10% by weight, more preferably 1 to 5% by weight, based on the total weight of the ultraviolet screening composition according to the present invention.
본 발명에 따른 자외선 차단용 조성물은 수용성 유기 자외선 차단제와 함께, 선택적으로 무기 자외선 차단제를 포함한다. The ultraviolet screening composition according to the present invention optionally comprises an inorganic ultraviolet screening agent together with a water-soluble organic ultraviolet screening agent.
무기 자외선 차단제는 자외선 산란, 반사 효과가 있으나 백탁 현상이 일어날 수 있다. 예컨대, 이산화티탄, 산화아연 및 지르코늄옥사이드, 칼슘 세륨 옥사이드, 티타늄디옥사이드, 징크옥사이드 등이 포함될 수 있으나, 이에 제한되지 않는다. Inorganic sunscreen agents have ultraviolet scattering and reflection effects, but they can become cloudy. But are not limited to, titanium dioxide, zinc oxide and zirconium oxide, calcium cerium oxide, titanium dioxide, zinc oxide, and the like.
본 발명에 따른 자외선 차단용 조성물의 총 중량 대비 무기 자외선 차단제는 1 - 10 중량%로 포함되며, 보다 바람직하게 5 - 10 중량%로 포함될 수 있다. 본 발명에 있어서, 수용성 유기 자외선 차단제의 총 중량 대비 무기 자외선 차단제의 총 중량 비율은 1: 1 - 5이며, 보다 바람직하게 1: 1 - 4이다. 1: 1 미만의 경우 충분한 자외선 차단 기능을 확보하지 못하는 문제가 있으며, 1: 5 초과의 경우 백탁현상이 생길 수 있다. The inorganic UV blocking agent may be contained in an amount of 1 to 10% by weight, and more preferably 5 to 10% by weight, based on the total weight of the UV blocking composition of the present invention. In the present invention, the total weight ratio of the inorganic ultraviolet screening agent to the total weight of the water-soluble organic ultraviolet screening agent is 1: 1-5, and more preferably 1: 1-4. If the ratio is less than 1: 1, there is a problem that sufficient ultraviolet shielding function can not be secured. If the ratio is more than 1: 5, whitening may occur.
본 발명에 따른 자외선 차단용 조성물은 유중수형 타입이다. 즉, 외상이 유상이고 내상이 수상인 타입이다. 유상에는 유상 성분이 포함되고, 수상에는 수상 성분이 포함된다. The ultraviolet screening composition according to the present invention is a water-in-oil type. In other words, it is a type in which the trauma is oil-based and the internal wound is water-based. The oil phase contains an oil component, and the water phase contains a water component.
본 발명에 있어서, 수상 성분은 자외선 차단용 조성물의 총 중량 대비 20 - 90 중량%, 30 - 90 중량%, 또는 30 - 70 중량% 일 수 있다. 20 중량% 미만인 경우 점도가 지나치게 낮고, 70 중량% 초과인 경우 점도가 지나치게 높아 제형의 안정도가 낮아진다. In the present invention, the water phase component may be 20-90 wt%, 30-90 wt%, or 30-70 wt%, based on the total weight of the ultraviolet screening composition. If it is less than 20% by weight, the viscosity is too low, and if it is more than 70% by weight, the viscosity is too high and the stability of the formulation is lowered.
본 발명에 따른 자외선 차단용 조성물의 수상 성분에는 당업계에서 자외선 차단용 조성물에 수상 성분으로 통상 사용 가능한 다양한 성분이 포함될 수 있다. 수용성 유기 자외선 차단제가 포함되며, 이외에, 예컨대 정제수를 포함하는 용제, 보습제, 금속이온 봉쇄제, 산화방지제, 수용성 약제, 중화제 등이 포함될 수 있으며, 이에 제한되지 않는다. The ultraviolet barrier composition according to the present invention may contain various components that can be generally used as a waterborne component in the ultraviolet barrier composition in the art. A water-soluble organic sunscreen agent, and may include, for example, a solvent including purified water, a moisturizer, a sequestering agent, an antioxidant, a water-soluble agent, a neutralizing agent, and the like.
보습제로서는, 예컨대 1,3-부티렌글리콜, 폴리에틸렌글리콜, 프로필렌글리콜, 디프로필렌글리콜, 헥실렌글리콜, 글리세린, 디글리세린, 자일리톨, 말티톨, 말토오스, D-만니톨 등을 들 수 있다. 금속이온 봉쇄제로서는, 에데트산 나트륨염, 메타인산 나트륨, 인산 등을 들 수 있다. 산화방지제로서는, 예컨대 아스코르브산, 디부틸히드록시톨루엔, 부틸히드록시아니솔 등을 들 수 있다. 수용성 약제로서는, 예컨대 이노시톨, 염산피리독신, 니코틴산 벤질, 니코틴산 아미드, 니코틴산 dl-α-토코페롤, 아스코르브산인산마그네슘, 아스코르브산2-글루코시드, dl-α-토코페롤2-L아스코르브산인산디에스테르칼륨염, 판토텐산, 비오틴 등의 비타민류, 알란토인, 아쥴렌 등의 항염증제, 알부틴, 4-메톡시살리실산 또는 그 염, 트라넥삼산 또는 그 유도체 등의 미백제, 탄닌산 등의 수렴제, 염화라이소자임, 염산피리독신, 마린 콜라겐 등을 들 수 있다. 또한, 상기 약제는 유리 상태로 사용되는 이외에, 조염 가능한 것은 산 또는 염기의 염의 형태로, 또한 카르복실산기를 갖는 것은 그의 에스테르 형태로 사용할 수 있다. 중화제로서는, 예컨대 트로메타민(Tromethamine)과 트리에틸아민(Triethylamine)과 같은 1차, 3차 아민 혹은 2차 아민 등을 들 수 있다. Examples of the moisturizing agent include 1,3-butylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, hexylene glycol, glycerin, diglycerin, xylitol, maltitol, maltose and D-mannitol. Examples of the metal ion sequestering agent include sodium edetate, sodium metaphosphate and phosphoric acid. Examples of the antioxidant include ascorbic acid, dibutylhydroxytoluene, butylhydroxyanisole and the like. Examples of the water-soluble drug include dicarboxylic acid diester salts such as inositol, pyridoxine hydrochloride, benzyl nicotinate, nicotinic acid amide, nicotinic acid dl- alpha -tocopherol, ascorbic acid magnesium phosphate, ascorbic acid 2- glucoside, dl- alpha -tocopherol 2-L ascorbic acid diester potassium salt, Vitamins such as pantothenic acid and biotin, antiinflammatory agents such as allantoin and azulene, whitening agents such as arbutin, 4-methoxysalicylic acid or its salt and tranexamic acid or its derivative, astringent such as tannic acid, lysozyme chloride, pyridoxine hydrochloride, . Further, in addition to being used in a free state, the medicament can be used in the form of an acid or a salt of a salt capable of forming a salt, and having a carboxylic acid group, in the form of an ester thereof. Examples of the neutralizing agent include primary, tertiary or secondary amines such as tromethamine and triethylamine.
본 발명의 구체적인 실시예에 따르면, 수상 성분은 수용성 자외선 차단제, 중화제 및 용제로 이루어져 있다. According to a specific embodiment of the present invention, the aqueous phase component comprises a water-soluble ultraviolet screening agent, a neutralizing agent and a solvent.
본 발명에 있어서, 유상 성분은 자외선 차단용 조성물의 총 중량 대비 10 - 60 중량%, 20 - 45 중량%, 또는 30 - 45 중량% 일 수 있다. 10 중량% 미만인 경우 무기분체의 분산성이 불량하고 점도가 너무 높아 안정성이 떨어지며, 60 중량% 초과의 경우 유분감이 강하다. In the present invention, the oily component may be 10-60 wt%, 20-45 wt%, or 30-45 wt%, based on the total weight of the ultraviolet screening composition. When the content is less than 10% by weight, the dispersibility of the inorganic powder is poor and the viscosity is too high, resulting in poor stability. When the content is more than 60% by weight, oiliness is strong.
본 발명에 따른 자외선 차단용 조성물의 유상 성분에는 당업계에서 자외선 차단용 조성물에 유상 성분으로 통상 사용 가능한 다양한 성분이 포함될 수 있다. 예컨대, 실리콘 유분, 극성 유분, 비극성 유분 등의 액상 유분, 고형 유분, 반고형 유분을 들 수 있으며, 이에 제한되지 않는다. The oily component of the ultraviolet screening composition according to the present invention may contain various components that can be generally used as an oily component in the ultraviolet screening composition in the art. Examples thereof include, but are not limited to, liquid oil fractions such as silicone oil, polar oil, and non-polar oil, solid oil, and semi-solid oil.
실리콘 유분으로서는, 예컨대 디메틸폴리실록산, 메틸페닐폴리실록산, 메틸하이드로겐폴리실록산, 옥타메틸시클로테트라실록산, 데카메틸시클로펜타실록산, 도데카메틸시클로헥사실록산, 메칠트리메치콘, 페닐트리메치콘, 디메치콘, 사이클로메치콘 등의 실리콘유 등을 들 수 있다. 극성 유분으로서는, 예컨대 디이소스테아르산 글리세릴, 말산 디이소스테아릴, 피발산 트리프로필렌글리콜, 트리2-에틸헥산산 글리세릴, 옥탄산 세틸, 라우르산 헥실, 미리스트산 이소프로필, 팔미트산 옥틸, 스테아르산이소세틸, 이소스테아르산 이소프로필, 이소팔미트산 옥틸, 이소스테아르산 이소데실, 숙신산2-에틸헥실, 세바스산디에틸, 에틸헥산산 세틸 등의 에스테르유 등을 들 수 있다. 비극성 유분으로서는, 예컨대 유동파라핀, 스쿠알란, 스쿠알렌, 파라핀, 이소헥사데칸 등의 탄화수소유 등을 들 수 있다. 고형 유분으로서는, 예컨대 카카오지, 야자유, 마유, 경화야자유, 팜유, 우지, 양지, 경화피마자유 등의 고체 유지, 파라핀 왁스(직쇄탄화수소), 미세결정질 왁스(분지쇄 포화탄화수소), 세레신 왁스, 목랍, 피셔트롭쉬 왁스 등의 탄화수소류, 밀랍, 카르나우바 왁스, 칸데릴라 왁스, 쌀겨 왁스(라이스 왁스), 경랍, 호호바유, 겨왁스, 몬탄 왁스, 케이폭 왁스, 베이베리 왁스, 셸락 왁스, 사탕수수 왁스, 라놀린 지방산 이소프로필, 라우르산 헥실, 환원 라놀린, 경질 라놀린, POE 라놀린알콜에테르, POE 라놀린알콜아세테이트, POE 콜레스테롤에테르, 라놀린 지방산 폴리에틸렌글리콜, POE 수소첨가 라놀린알콜에테르 등의 왁스류, 미리스트산, 팔미트산, 스테아르산, 베헨산 등의 고급 지방산 등을 들 수 있다. 반고형 유분으로서는, 예컨대 바세린, 라놀린, 시어 버터, 부분 수첨 야자유 등의 식물지, 부분 수첨 호호바유, 비스디글리세릴폴리아실아디페이트-2, 테트라(베헨산/벤조산/에틸헥산산)펜타에리스리틸, 마카데미아너트유폴리글리세릴-6-에스테르즈베헤네이트, 다이머디리놀레산(피토스테릴/베헤닐), 헥사옥시스테아르산 디펜타에리스리톨 등을 들 수 있다.Examples of the silicone oil include silicone oils such as dimethylpolysiloxane, methylphenylpolysiloxane, methylhydrogenpolysiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, methyltrimethicone, phenyltrimethicone, dimethicone, And silicone oil such as chicone. Examples of the polar oil fraction include glyceryl diisostearate, diisostearyl malate, tripropylene glycol pivalate, glyceryl tri-2-ethylhexanoate, cetyl octanoate, hexyl laurate, isopropyl myristate, Octyl stearate, isostearyl stearate, isopropyl stearate, isopropyl isostearate, octyl isolefate, isodecyl isostearate, 2-ethylhexyl succinate, diethyl sebacate and cetyl ethylhexanoate. Examples of the nonpolar oil include hydrocarbon oils such as liquid paraffin, squalane, squalane, paraffin, and isohexadecane. Examples of the solid oil include solid fats such as cacao butter, coconut oil, coconut oil, hardened coconut oil, palm oil, tallow, sunflower and hardened castor oil, paraffin wax (straight chain hydrocarbon), microcrystalline wax (branched chain saturated hydrocarbon), ceresin wax, , Fischer Tropsch wax, wax, carnauba wax, candelilla wax, rice bran wax (rice wax), wax, jojoba oil, wax wax, montan wax, kapok wax, bayberry wax, shellac wax, candy Waxes such as castor wax, isopropyl lanolate, hexyl laurate, reduced lanolin, hard lanolin, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, POE hydrogenated lanolin alcohol ether, And higher fatty acids such as lysic acid, palmitic acid, stearic acid, and behenic acid. Examples of semi-solid oil include vegetable plants such as vaseline, lanolin, shea butter, partially hydrogenated palm oil, partially hydrogenated jojoba oil, bisdiglyceryl polyacyl adipate-2, tetra (behenic acid / benzoic acid / ethylhexanoic acid) , Macadamia nut polyglyceryl-6-ester behenate, dimer delinoleic acid (phytosteryl / behenyl), and hexaoxystearic acid dipentaerythritol.
본 발명에 따른 자외선 차단용 조성물의 유상 성분에는 휘발성 오일이 포함되며, 유상 성분의 총 중량 대비 80 중량% 이상이 휘발성 오일이다. The oil component of the ultraviolet screening composition according to the present invention includes volatile oil, and 80% by weight or more of the total weight of the oil component is volatile oil.
본 발명에 있어서, 상기 휘발성 오일은 당업계에서 자외선 차단용 조성물의 제조를 위해 사용되는 휘발성 오일이라면 제한하지 않고 포함될 수 있다. 휘발성 오일에 해당하는 성이 조성물 내에서 발휘하는 기능에 따라 다양하게 지칭될 수 있으나, 휘발성 오일에 해당된다면, 본 발명의 휘발성 오일로 본다. 상술한 유상 성분으로 포함될 수 있는 성분들로 예시한 실리콘 유분, 극성 유분, 비극성 유분 등의 액상 유분, 고형 유분, 반고형 유분 중에서도 휘발성 오일에 속하면, 본 발명의 휘발성 오일로 판단한다. 바람직하게, 본 발명에서 사용하는 휘발성 오일은 휘발성 실리콘유일 수 있다. In the present invention, the volatile oil may be included without limitation as long as it is a volatile oil used in the art for the production of a UV-blocking composition. The properties corresponding to volatile oils can be variously referred to as functions in the composition, but they are regarded as the volatile oils of the present invention if they correspond to volatile oils. It is judged that the volatile oil of the present invention belongs to the volatile oil among liquid oils such as silicone oil, polar oil and non-polar oil, solid oil oil and semi-solid oil oil exemplified as the above-mentioned oil phase components. Preferably, the volatile oil used in the present invention is volatile silicone only.
본 발명에 있어서, 상기 휘발성 오일은 온도 증기압이 40℃에서 0.3 내지 70㎜Hg 범위내의 증기압을 갖도록 하는 것이 바람직하나, 이에 제한되지 않는다.In the present invention, it is preferable that the volatile oil has a vapor pressure within a range of 0.3 to 70 mmHg at 40 DEG C, but is not limited thereto.
본 발명에 있어서, 상기 휘발성 오일은 단일 종류의 오일을 사용하거나 또는 2 종류 이상의 오일을 혼합하여 요구되는 휘발조건에 맞게 선택할 수 있는데, 예컨대 사이클로펜타실록산 및 메칠트리메치콘을 1 : 1 - 3 또는 1 : 1 - 2의 중량비율로 혼합하여 사용할 수 있다. 이와 같은 조성비로 휘발성 오일을 제조할 경우에는 사이클로펜타실록산의 함량이 조성물의 총 중량 대비 15 중량% 이상 30 중량% 이하가 되도록 하는 것이 바람직하다. In the present invention, the volatile oil can be selected in accordance with the required volatilization conditions by using a single kind of oil or a mixture of two or more types of oils. For example, cyclopentasiloxane and methyltrimethicone are used in a ratio of 1: 1 to 3: 1: 1 - 2 by weight. When the volatile oil is produced at such composition ratio, it is preferable that the content of the cyclopentasiloxane is 15 wt% or more and 30 wt% or less based on the total weight of the composition.
본 발명에 있어서, 상기 휘발성 오일은 유상 성분의 총 중량 대비 80 중량% 이상으로 포함된다. 바람직하게 98 중량% 이하로 포함될 수 있다. 80 중량% 미만의 경우, 휘발속도가 늦어 분비된 땀이나 피지를 충분히 흡수하지 못하며, 끈적임과 유분감이 없거나 현격히 증가한다. In the present invention, the volatile oil is contained in an amount of 80% by weight or more based on the total weight of the oil phase components. Preferably not more than 98% by weight. If it is less than 80% by weight, the volatilization rate is too slow to sufficiently absorb secreted perspiration or sebum, and there is no stickiness and oily feeling or remarkably increases.
본 발명에 있어서, 본 발명에 따른 자외선 차단용 조성물의 유상 성분에는 휘발성 오일 외에, 비휘발성 오일도 포함될 수 있으나, 실질적으로 포함하지 않는 것이 바람직하다. In the present invention, the oily component of the ultraviolet screening composition according to the present invention may include, but not substantially contain, volatile oil as well as nonvolatile oil.
또한, 본 발명에 있어서, 본 발명에 따른 자외선 차단용 조성물의 유상 성분에는 유화제가 포함될 수 있다. 상기 유화제는 HLB 범위가 1~6으로 HLB가 낮은 비이온 계면활성제가 바람직하며, 예컨대 PEG/PPG-18/18 디메치콘(Cyclopentasiloxane and PEG/PPG-18/18 Dimethicone), 글리콜 스테아레이트(Glycol Stearate), 소르비탄 세스퀴올레이트(Sorbitan Sesquioleate), 글리세릴 올레이트(Glyceryl Oleate), 글리콜 디스테아레이트(Glycol Distearate), 프로필렌글리콜 모노스테아레이트(Propylene Glycol Monostearate), 글리세릴 스테아레이트(Glyceryl Stearate), 소르비탄 스테아레이트(Sorbitan Stearate), PEG-30 디폴리히드록시스테아레이트(PEG-30 Dipolyhydroxystearate), PEG-10 디메치콘(PEG-10 Dimethicone), 사이클로펜타실록산/ PEG.PPG-19.19 디메치콘(Cyclopentasiloxane/PEG.PPG-19.19 Dimethicone), 소르비탄 이소스테아레이트(Sorbitan Isostearate), 라우릴 PEG.PPG-18.18 메치콘(Lauryl PEG.PPG-18.18 Methicone), 세틸 PEG.PPG-10.1 디메치콘(Cetyl PEG.PPG-10.1 Dimethicone), 라우릴 PEG-9 폴리디메틸실록시에틸 디메치콘(Lauryl PEG-9 PolydimethylsiloxyethylDimethicone) 등이 사용될 수 있으나, 이에 제한되지 않는다. 조성물 총 중량에 대하여 0.1 - 10중량%의 양으로 함유될 수 있다. 유화제가 0.1중량% 미만이면 에멀젼이 형성되지 않거나 조성물의 안정도가 나쁘며, 10중량% 초과이면 유화제 자체의 끈적임과 고유한 이취가 심하게 발생이 될 수 있다. 본 발명의 구체적인 실시예에 따르면, 유상 성분은 휘발성 오일, 유화제, 및 선택적으로 비휘발성 오일로 이루어져 있다. In the present invention, an emulsifier may be included in the oily component of the ultraviolet screening composition according to the present invention. The emulsifier is preferably a non-ionic surfactant having an HLB range of 1 to 6 and a low HLB, such as PEG / PPG-18/18 Dimethicone, PEG / PPG-18/18 Dimethicone, Glycol Stearate Sorbitan Sesquioleate, Glyceryl Oleate, Glycol Distearate, Propylene Glycol Monostearate, Glyceryl Stearate, Glyceryl Stearate, Sorbitan Stearate, PEG-30 Dipolyhydroxystearate, PEG-10 Dimethicone, Cyclopentasiloxane / PEG.PPG-19.19 Dimyclocene (Cyclopentasiloxane) / PEG.PPG-19.19 Dimethicone, Sorbitan Isostearate, Lauryl PEG.PPG-18.18 Methicone, Cetyl PEG.PPG-10.1 Dimethicone. PPG-10.1 Dimethicone), Lau PEG-9 Poly dimethylsiloxy ethyl dimethicone (PEG-9 Lauryl PolydimethylsiloxyethylDimethicone) although such may be used, not limited to this. May be contained in an amount of 0.1 to 10% by weight based on the total weight of the composition. When the emulsifier is less than 0.1% by weight, the emulsion is not formed or the stability of the composition is poor. If the emulsifier is more than 10% by weight, stickiness of the emulsifier itself and inherent odor may occur severely. According to a specific embodiment of the present invention, the oily component consists of a volatile oil, an emulsifier, and optionally a non-volatile oil.
본 발명에 따른 자외선 차단용 조성물은 유상 성분 및 수상 성분 외에, 분체를 포함할 수 있다. 바람직하게, 본 발명에 따른 조성물은 유상 성분, 수상 성분 및 분체로 이루어질 수 있다. The ultraviolet screening composition according to the present invention may contain a powder in addition to the oil component and the water component. Preferably, the composition according to the present invention may comprise an oil component, an aqueous component and a powder.
본 발명에 있어서, 분체는 자외선 차단용 조성물의 총 중량 대비 1 - 40 중량%, 또는 10 - 20 중량% 일 수 있다. 1 중량% 미만의 경우 색소로 인한 색상표현, 발색력이나, 원하는 정도의 자외선 차단지수가 얻어질 수 없고, 40 중량%를 초과하는 경우에는, 분체 고유의 건조함으로 사용감이 떨어지고, 유화 안정성이 떨어지는 현상이 발생하게 된다.In the present invention, the powder may be 1-40% by weight or 10-20% by weight based on the total weight of the ultraviolet screening composition. If it is less than 1% by weight, the color expression or coloring ability due to the coloring matter or the desired degree of ultraviolet barrier property can not be attained. If the content is more than 40% by weight, the feeling of use is deteriorated due to inherent drying property of the powder, .
본 발명에 따른 자외선 차단용 조성물의 분체에는 당업계에서 자외선 차단용 조성물에 분체로 통상 사용 가능한 다양한 성분이 포함될 수 있다. 예컨대, 평균입도가 5~300nm인 산화철, 평균입도가 5~1000nm인 이산화티탄, 산화울트라 마린, 크로미늄 옥사이드 그린, 크로미늄 하이드록사이드 그린, 타르색소 등이 포함되는 안료; 무기 자외선 차단제; 및 메칠메타크릴레이트크로스폴리머, 실리카, 나일론파우더, 폴리우레탄, 펄, 합성마이카, 탈크, 카올린, 세라사이트, 바륨설페이트, 알루미나, 보론나이트라이드, 비스무스옥시클로라이드, 폴리에틸렌파우더 및 폴리에틸렌프탈레이트-폴리메틸메타크릴레이트 라미네이트 등이 포함되는 흡유성 분체 내지 폴리머 등이 사용될 수 있다. The ultraviolet screening composition powder according to the present invention may contain various components which can be generally used in powder form in the ultraviolet screening composition in the art. For example, pigments include iron oxide having an average particle size of 5 to 300 nm, titanium dioxide having an average particle size of 5 to 1000 nm, oxidized ultramarine, chromium oxide green, chromium hydroxide green, tar pigment and the like; Inorganic sunscreen agents; And a binder such as methyl methacrylate crosspolymer, silica, nylon powder, polyurethane, pearl, synthetic mica, talc, kaolin, cerasite, barium sulfate, alumina, boron nitride, bismuth oxychloride, polyethylene powder and polyethylene phthalate- And oil absorbing powders or polymers containing a rubber latex or the like can be used.
상기 흡유성 분체 내지 폴리머는 조성물 총 중량 대비 1 - 10 중량%로 포함되며, 1 중량% 미만의 경우 최종 조성물에서 오일이 배어나오는 현상이 발생하고, 10 중량% 초과의 경우 점도가 높아 사용감이 불량하고, 유화 안정도가 떨어진다 The oil absorbing powder or polymer is contained in an amount of 1 to 10% by weight based on the total weight of the composition. When the amount is less than 1% by weight, the oil escapes from the final composition. When the amount is more than 10% by weight, And the emulsion stability is lowered.
본 발명에 따른 자외선 차단용 조성물은 우수한 자외선 차단 효과를 갖는바, 바람직하게 자외선 차단지수(Sun Protection Factor, SPF) 40 이상일 수 있다. 보다 바람직하게 SPF 40 - 70 일 수 있다. The composition for protecting ultraviolet rays according to the present invention has an excellent ultraviolet shielding effect, and may preferably have a sun protection factor (SPF) of 40 or more. More preferably SPF 40-70.
상기 “자외선 차단지수(Sun Protection Factor, SPF)”는 UVB를 차단하는 제품의 차단효과를 나타내는 지수로 자외선차단제품을 도포하여 얻은 최소홍반량을 자왼선차단제품을 도포하지 않고 얻은 최소홍반량으로 나눈 값을 의미한다. 상기 “최소홍반량(Minumum Erythema Dose, MED)”은 UVB를 사람의 피부에 조사한 후 16~24시간의 범위내에, 조사영역의 전 영역에 홍반을 나타낼 수 있는 최소한의 자외선 조사량을 말한다. 자외선 차단지수 측정방법으로서, 피험자선정, 시험부위, 제품 무도포부위의 최소홍반량 측정, 제품 도포부위 최소홍반량 측정, 광원선정, 표준시료, 제품 도포량, 제품 도포면적 및 조사부위의 구획, 광량증가, 자외선차단지수 계산, 및 자외선차단지수 표시방법은 한국 식품의약품안전처고시 제2013-28호, 2013.4.5. 시행, 「기능성화장품 심사에 관한 규정」의 별표 3의 제2장 자외선차단지수(SPF) 측정방법에 고시된 바에 따른다. The "Sun Protection Factor (SPF)" is an index indicating the blocking effect of the UVB blocking product. The minimum erythema obtained by applying the ultraviolet screening product is the minimum erythema amount obtained without applying the left screening product It means divided value. The " Minumum Erythema Dose (MED) " refers to the minimum amount of ultraviolet radiation that can indicate erythema in the entire area of the irradiation area within a range of 16 to 24 hours after irradiation of human skin with UVB. As a method of measuring ultraviolet shielding index, there is a method of selecting a subject, a test site, a minimum erythema measurement at a site where a product is not coated, a minimum erythema measurement at a product application site, a light source selection, a standard sample, Increase, calculation of ultraviolet barrier index, and indication of ultraviolet barrier index are to be submitted to Korea Food & Drug Administration Notice No. 2013-28, April 5, 2013. (SPF) measurement method specified in Attachment 3 of Annex 3 of the 「Regulation on the Examination of Functional Cosmetics」.
본 발명에 따른 자외선 차단용 조성물은 성분의 종류, 함량 및 제형 등을 고려하여, 당업계 통상의 유중수형 타입의 자외선 차단용 조성물을 제조하는 방법에 따라 제조할 수 있다. The composition for protecting ultraviolet rays according to the present invention can be produced by a method for producing ultraviolet ray blocking composition of the conventional water-in-oil type in the art in consideration of kinds, contents, formulations and the like of the components.
예컨대, 다음의 단계를 포함하여 유중수형의 자외선 차단용 조성물을 제조할 수 있다:For example, a water-in-oil type UV blocking composition can be prepared including the following steps:
(S1) 유상 성분을 가열 용해시킨 후 분체를 첨가하여 분산시키는 단계; 및(S1) heating and dissolving the oil phase component and adding and dispersing the powder; And
(S2) 수상 성분을 가열 용해시킨 후 (S1) 단계의 결과물에 첨가하여 유화시키는 단계를 포함하고, (S2) heating and dissolving the aqueous phase component, and then adding it to the resultant product of step (S1)
ⅰ. 자외선 차단용 조성물에 유기 자외선 차단제를 포함하되, 상기 유기 자외선 차단제로 수용성 유기 자외선 차단제가 선택되며, I. A water-soluble organic sunscreen agent is selected as the organic ultraviolet screening agent,
ⅱ. 유상 성분의 총 중량 대비 80 중량% 이상이 휘발성 오일인 것을 특징으로 함. Ii. And 80% by weight or more based on the total weight of the oil phase components is volatile oil.
본 발명에 따른 자외선 차단용 조성물은 예컨대, 메이크업 프라이머, 메이크업베이스, 파운데이션, 스킨커버, 립스틱, 립그로스, 페이스파우더, 립라이너펜슬, 아이브라우펜슬, 아이섀도, 치크칼라, 콤팩트파우더, 트윈케익, 팩트, 파우더팩트, 아이브라우, 아이섀도우, 컨실러, 블러셔, 파우더 파운데이션 또는 에어리스 등으로 제형화 될 수 있으나, 이에 제한되지 않는다. The composition for protecting ultraviolet rays according to the present invention can be applied to various cosmetics such as makeup primer, makeup base, foundation, skin cover, lipstick, lip gloss, face powder, lip liner pencil, eyebrow pencil, eye shadow, cheek color, compact powder, But not limited to, a powder, a powder, an eyebrow, an eye shadow, a concealer, a blusher, a powder foundation or an airless.
본 발명에 따르면, 끈적임이 줄어들어 사용감이 뛰어나면서 제형 안정성이 개선된 우수한 자외선 차단 효과를 갖는 유중수형 타입의 자외선 차단 화장료 조성물 및 이의 제조방법을 제공할 수 있다. According to the present invention, it is possible to provide a water-in-oil type ultraviolet ray blocking cosmetic composition having excellent ultraviolet shielding effect with improved stability in formulation with reduced feeling of tactility and a method for producing the same.
이하, 본 발명의 이해를 돕기 위하여 실시예 등을 들어 상세하게 설명하기로 한다. 그러나, 본 발명에 따른 실시예들은 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 하기 실시예들에 한정되는 것으로 해석되어서는 안 된다. 본 발명의 실시예들은 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이다.Hereinafter, embodiments of the present invention will be described in detail to facilitate understanding of the present invention. However, the embodiments according to the present invention can be modified into various other forms, and the scope of the present invention should not be construed as being limited to the following embodiments. Embodiments of the invention are provided to more fully describe the present invention to those skilled in the art.
<< 실시예> 유중수형Examples> Water-in-oil type 자외선 차단용 조성물 제조 Preparation of composition for ultraviolet shielding
아래 표 1에 기재된 성분 및 함량으로 유중수형 자외선 차단용 조성물을 제조하였다. A water-in-oil UV blocking composition was prepared by the ingredients and contents shown in Table 1 below.
비교예 1 및 비교예 2에서는 유용성 유기 자외선 차단제(에칠헥실메톡시신나메이트(EHMC))를 포함하는데 반해, 실시예 1 - 3에서는 유용성 유기 자외선 차단제는 전혀 포함하지 않고 수용성 유기 자외선 차단제(페닐벤즈이미다졸설포닉애씨드(PBSA))를 포함하여 유중수형 자외선 차단용 조성물을 제조하였다. 그리고 실시예 1 - 3에서는, 유상 성분의 총 중량 대비 80 중량% 이상의 휘발성 오일을 사용하였다. In Comparative Examples 1 and 2, an oil-soluble organic ultraviolet screening agent (EHMC) was included in Examples 1 to 3. In Examples 1 to 3, Imidazosulfoneic acid (PBSA)) to prepare a water-in-oil type UV blocking composition. In Example 1-3, volatile oil of 80% by weight or more based on the total weight of the oil phase components was used.
(단위: wt.%)(Unit: wt.%)
유중수형 자외선 차단용 조성물은 다음과 같이 제조하였다: A water-in-oil type UV blocking composition was prepared as follows:
상기 표 1에 기재된 중량%에 따라, 유상조에 유상 성분을 넣고, 80℃로 열을 가하여 균일하게 한 후, 분체를 넣고 균질화기를 사용하여 분산시켰다. 수상조에는 수상 성분을 넣고, 80℃로 열을 가하여 원료를 완전히 용해시킨 후, 유상 성분과 분체가 분산되어 있는 유상조에 천천히 첨가하여 호모믹서로 유화하였다. 그리고,조성물을 기밀 용기에 채우고 냉각기를 사용하여 실온으로 냉각하였다. According to the weight% shown in Table 1, the oil component was added to the oil bath, and the mixture was heated at 80 DEG C to make it uniform. The powder was then added and dispersed using a homogenizer. The water component was added to the water tank, and the raw material was completely dissolved by heating at 80 DEG C, and then slowly added to the oil bath in which the oil component and the powder were dispersed and emulsified by a homomixer. The composition was then filled into an airtight container and cooled to room temperature using a cooler.
<< 실험예Experimental Example > > 유중수형Water type 자외선 차단용 조성물의 평가 Evaluation of UV-screening composition
1. 자외선 자단 기능 평가1. Evaluation of UV radiation function
비트로스킨(Vitro Skin)에 2mg/cm2으로 비교예 1 및 2와 실시예 1 - 3의 시료를 도포하고 건조상태에서 자외선차단지수 측정기(SPF-290S)를 이용하여 SPF 수치를 측정함으로써 자외선 차단 능력(SPFdry)을 평가하였다. The samples of Comparative Examples 1 and 2 and Examples 1 to 3 were applied to Vitro Skin at 2 mg / cm 2 , and SPF values were measured using an ultraviolet barrier index measuring device (SPF-290S) The ability (SPFdry) was evaluated.
2. 유분감 평가2. Evaluation of oiliness
비트로스킨(Vitro Skin)에 2mg/cm2으로 비교예 1 및 2와 실시예 1 - 3의 시료를 도포한 후 3M Blue Masic Oil Control Film을 그 위에 올려 오일이 배어나오는 면적을 측정하여 유분감을 비교하였다.After applying the samples of Comparative Examples 1 and 2 and Examples 1 to 3 to Vitro Skin at 2 mg / cm 2 , 3M Blue Masic Oil Control Film was placed thereon, Respectively.
유분감을 3등급화 하였으며, 각각 오일의 배어나오는 면적이 30%초과, 30%~10%및 10%미만이면, X, ○ 및 ◎로 기재하였다. The oiliness was graded 3, and when X, O, and ⊚ were described, respectively, when the oil exuding area exceeded 30%, 30% to 10%, and 10%, respectively .
3. 끈적임 평가 3. Evaluation of Stickiness
비트로스킨(Vitro Skin)에 2mg/cm2으로 비교예 1 및 2와 실시예 1 - 3의 시료를 도포한 후, 3mm 사이즈의 스티로폼 볼을 뿌린 후 뒤집어 스티로폼볼이 붙어있는 갯수를 비교하여 끈적임을 측정하였다. 표 2에는 스티로폼볼의 갯수를 기재하였다. After applying the samples of Comparative Examples 1 and 2 and Examples 1 to 3 at 2 mg / cm 2 on a Vitro Skin, a styrofoam ball of 3 mm size was sprayed, and the number of styrofoam balls attached to the styrofoam ball was compared to measure stickiness Respectively. Table 2 lists the number of styrofoam balls.
4. 유화 안정성 평가4. Evaluation of emulsion stability
비교예 1 및 2와 실시예 1 - 3의 시료에 대하여 40℃에서 4주간 상의 변화를 관찰하여 측정하였다. The samples of Comparative Examples 1 and 2 and Examples 1 to 3 were observed by observing the phase change at 40 占 폚 for 4 weeks.
유화안정성을 3등급화 하였으며, 각각 상 변화의 정도가 경시후 조성물의 상층부에 투명오일이 올라오는 정도가 1mm초과, 1mm이하 및 0 이면, X, ○ 및 ◎로 기재하였다.The emulsification stability was graded as 3, and the degree of phase change was expressed as X, O and ⊚ when the extent to which the transparent oil came up in the upper layer of the composition after aging was more than 1 mm, less than 1 mm and 0, respectively.
상술한 4가지 평가 결과는 표 2에 기재하였다. The above-mentioned four evaluation results are shown in Table 2.
평가 결과, 비교예 1 및 2에 비해, 실시예 1 - 3은 SPF 40 이상의 고 자외선 차단 기능(SPF 40~70)을 가지면서도, 관능평가 결과 끈적임과 유분감이 없거나 미미하였으며, 제형 안정성이 뛰어났다. As a result of the evaluation, it was found that Examples 1 to 3 had a high ultraviolet shielding function (SPF 40 to 70) of SPF 40 or more, and had no stickiness, no or little oiliness, and were excellent in formulation stability as compared with Comparative Examples 1 and 2 .
Claims (8)
ⅰ. 유기 자외선 차단제를 포함하되, 상기 유기 자외선 차단제로 수용성 유기 자외선 차단제가 선택되며,
ⅱ. 유상 성분의 총 중량 대비 80 중량% 이상이 휘발성 오일인 것을 특징으로 하는, 자외선 차단용 조성물. A UV-blocking composition for a water-in-oil type,
I. A water-soluble organic ultraviolet screening agent is selected as the organic ultraviolet screening agent,
Ii. Wherein at least 80% by weight based on the total weight of the oil phase components is a volatile oil.
(S1) 유상 성분을 가열 용해시킨 후 분체를 첨가하여 분산시키는 단계; 및
(S2) 수상 성분을 가열 용해시킨 후 (S1) 단계의 결과물에 첨가하여 유화시키는 단계를 포함하고,
상기 유중수형의 자외선 차단용 조성물은,
ⅰ. 자외선 차단용 조성물에 유기 자외선 차단제를 포함하되, 상기 유기 자외선 차단제로 수용성 유기 자외선 차단제가 선택되며,
ⅱ. 유상 성분의 총 중량 대비 80 중량% 이상이 휘발성 오일인 것을 특징으로 함.
A method for manufacturing a UV-blocking composition of a water-in-oil type comprising the steps of:
(S1) heating and dissolving the oil phase component and adding and dispersing the powder; And
(S2) heating and dissolving the aqueous phase component, and then adding it to the resultant product of step (S1)
The water-in-oil type ultraviolet-
I. A water-soluble organic sunscreen agent is selected as the organic ultraviolet screening agent,
Ii. And 80% by weight or more based on the total weight of the oil phase components is volatile oil.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150133531 | 2015-09-22 | ||
| KR20150133531 | 2015-09-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20170035345A true KR20170035345A (en) | 2017-03-30 |
| KR102624136B1 KR102624136B1 (en) | 2024-01-12 |
Family
ID=58503213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020160121719A KR102624136B1 (en) | 2015-09-22 | 2016-09-22 | High SPF W/O type cosmetic composition having no stickiness |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR102624136B1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019027194A1 (en) * | 2017-08-04 | 2019-02-07 | 코스맥스 주식회사 | Eye-makeup cosmetic composition having enhanced formability |
| KR20190015078A (en) * | 2017-08-04 | 2019-02-13 | 코스맥스 주식회사 | Cosmetic composition for eye make-up having enhanced formability |
| KR20200016117A (en) * | 2018-08-06 | 2020-02-14 | 코스맥스 주식회사 | Cosmetic composition for lip makeup with high temperature stability |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040030961A (en) * | 2001-08-17 | 2004-04-09 | 더 프록터 앤드 갬블 캄파니 | Sunscreen composition |
| JP2007217393A (en) * | 2006-02-20 | 2007-08-30 | Shiseido Co Ltd | Low-viscosity water-in-oil emulsion cosmetic |
| KR20150089517A (en) * | 2014-01-28 | 2015-08-05 | 코스맥스 주식회사 | Transparency spray type Sun Screening Cosmetic composition by Inorganic UV Filter |
-
2016
- 2016-09-22 KR KR1020160121719A patent/KR102624136B1/en active IP Right Grant
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040030961A (en) * | 2001-08-17 | 2004-04-09 | 더 프록터 앤드 갬블 캄파니 | Sunscreen composition |
| JP2007217393A (en) * | 2006-02-20 | 2007-08-30 | Shiseido Co Ltd | Low-viscosity water-in-oil emulsion cosmetic |
| KR20150089517A (en) * | 2014-01-28 | 2015-08-05 | 코스맥스 주식회사 | Transparency spray type Sun Screening Cosmetic composition by Inorganic UV Filter |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019027194A1 (en) * | 2017-08-04 | 2019-02-07 | 코스맥스 주식회사 | Eye-makeup cosmetic composition having enhanced formability |
| KR20190015078A (en) * | 2017-08-04 | 2019-02-13 | 코스맥스 주식회사 | Cosmetic composition for eye make-up having enhanced formability |
| KR20200016117A (en) * | 2018-08-06 | 2020-02-14 | 코스맥스 주식회사 | Cosmetic composition for lip makeup with high temperature stability |
Also Published As
| Publication number | Publication date |
|---|---|
| KR102624136B1 (en) | 2024-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101002866B1 (en) | Water-in-oil emulsion-type cosmetic composition for blocking ultraviolet ray | |
| AU686731B2 (en) | Solid lipophilic composition and process for its preparation | |
| JP6272764B2 (en) | Composition with continuous oil phase containing at least one lipophilic organic UV screening agent and airgel particles of hydrophobic silica | |
| KR101979217B1 (en) | Water in Oil Solid UV-Sunscreen Cosmetic Composition | |
| KR102496893B1 (en) | Water-in-oil emulsion solid cosmetic | |
| KR102005229B1 (en) | Oil in Water Type Macro Emulsion Cosmetic Composition for UV Protection | |
| KR101828852B1 (en) | Stick-shaped cosmetic for moisture replenishment | |
| EP1909749B1 (en) | Cosmetic composition for skin care | |
| JP6897779B2 (en) | Water emulsified stick-type deodorant in oil | |
| KR102375282B1 (en) | Cosmetic composition comprising Oil/IPDIcopolymer and having reversible phase transfer property when applied to the skin, and method for preparing the same | |
| KR100749893B1 (en) | Solid formed cosmetic composition for sunscreen | |
| US20110293543A1 (en) | Anhydrous composition comprising a dibenzoylmethane compound and a color pigment | |
| KR100749891B1 (en) | Solid formed cosmetic composition for sunscreen | |
| KR102211894B1 (en) | UV protection cosmetic composition comprising waterborne polyurethane | |
| KR102624136B1 (en) | High SPF W/O type cosmetic composition having no stickiness | |
| US8021674B2 (en) | Cosmetic gel product on the basis of oils and gelling agents | |
| KR100884480B1 (en) | Solid-type wax-free cosmetic composition for blocking ultraviolet ray | |
| US20110044919A1 (en) | Compositions With Perfluorinated Ingredients | |
| JP2007269763A (en) | Oily cosmetic | |
| KR101054884B1 (en) | Solid formed cosmetic composition for sunscreen | |
| KR20170061898A (en) | Oil in Water Emulsion Sunscreen Cosmetic Composition | |
| KR101444086B1 (en) | Multiphase cosmetic composition containing UV blocking agents | |
| KR102342903B1 (en) | Light screening cosmetic composition comprising cerium oxide | |
| EP2174691A1 (en) | Cosmetic core stick with a water based hard core part | |
| JP6733728B2 (en) | Stick-shaped cosmetic and method for producing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant |